PRAFELZO Trademark

Trademark Overview


On Thursday, January 5, 2012, a trademark application was filed for PRAFELZO with the United States Patent and Trademark Office. The USPTO has given the PRAFELZO trademark a serial number of 85509649. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Tuesday, November 6, 2012. This trademark is owned by Glaxo Group Limited. The PRAFELZO trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Gene and cell therapy
prafelzo

General Information


Serial Number85509649
Word MarkPRAFELZO
Filing DateThursday, January 5, 2012
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateTuesday, November 6, 2012
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesGene and cell therapy

Classification Information


International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, January 11, 2012
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Trademark Events


Event DateEvent Description
Tuesday, November 6, 2012ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Tuesday, November 6, 2012ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Tuesday, April 10, 2012NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, April 10, 2012NON-FINAL ACTION E-MAILED
Tuesday, April 10, 2012NON-FINAL ACTION WRITTEN
Tuesday, April 10, 2012ASSIGNED TO EXAMINER
Wednesday, January 11, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, January 9, 2012NEW APPLICATION ENTERED IN TRAM

Related Keywords


prafelzo therapy cell gene